Subscribe To
TearSolutions, Inc. Appoints Robert Dempsey to its Board of Directors
Dempsey brings worldwide Ophthalmology leadership experience in driving successful drug development CHARLOTTESVILLE, Va., Nov. 01, 2023 (GLOBE NEWSWIRE) — TearSolutions, Inc., a privately held biotech company developing potentially disruptive therapies for the treatment of Dry Eye Disease (DED) and other ocular surface related diseases, today announced that Robert Dempsey has been appointed to the Company’s […] The post TearSolutions, Inc. Appoints Robert Dempsey to its Board of Directors appear...
Read More
Posted: Nov 1 2023, 10:00
Author Name: forextv
Views: 112116